$0.4009
-4.1791[-91.25%]
Last update: 3:59PM Get Real Time Here
Axcella Health Inc
(OTC:AXLA)Axcella Health Inc Stock (OTC:AXLA), Analyst Ratings, Price Targets, Predictions
Axcella Health Inc has a consensus price target of $3.43, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., SVB Leerink, and HC Wainwright & Co. on February 16, 2023, December 16, 2022, and December 15, 2022. With an average price target of $0.67 between HC Wainwright & Co., SVB Leerink, and HC Wainwright & Co., there's an implied 66.29% upside for Axcella Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
SVB Leerink
Chardan Capital
SVB Leerink
Noble Capital Markets
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Axcella Health Inc
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/16/2023 | AXLA | Buy Now | Axcella Health | $0.40 | — | HC Wainwright & Co. | Ed Arce | — | Maintains | Neutral | Get Alert |
| 12/16/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 398.88% | SVB Leerink | Mike Kratky | $150 → $50 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/15/2022 | AXLA | Buy Now | Axcella Health | $0.40 | — | HC Wainwright & Co. | Ed Arce | — | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 1147.19% | Chardan Capital | Keay Nakae | $175 → $125 | Maintains | Buy | Get Alert |
| 10/03/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 2394.39% | HC Wainwright & Co. | Ed Arce | $200 → $250 | Maintains | Buy | Get Alert |
| 08/03/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 1895.51% | HC Wainwright & Co. | Ed Arce | $350 → $200 | Maintains | Buy | Get Alert |
| 08/03/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 1396.63% | SVB Leerink | Thomas Smith | $225 → $150 | Maintains | Outperform | Get Alert |
| 05/09/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 1646.07% | Chardan Capital | Keay Nakae | $300 → $175 | Maintains | Buy | Get Alert |
| 03/31/2022 | AXLA | Buy Now | Axcella Health | $0.40 | 2144.95% | SVB Leerink | Thomas Smith | $250 → $225 | Maintains | Outperform | Get Alert |
| 11/16/2021 | AXLA | Buy Now | Axcella Health | $0.40 | 2893.27% | Chardan Capital | Keay Nakae | — | Maintains | Buy | Get Alert |
| 10/12/2021 | AXLA | Buy Now | Axcella Health | $0.40 | 1396.63% | Noble Capital Markets | Robert LeBoyer | — | Initiates | → Outperform | Get Alert |
| 09/22/2021 | AXLA | Buy Now | Axcella Health | $0.40 | 1147.19% | Goldman Sachs | Paul Choi | — | Downgrade | Buy → Neutral | Get Alert |
| 07/30/2021 | AXLA | Buy Now | Axcella Health | $0.40 | — | JP Morgan | Jessica Fye | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/06/2021 | AXLA | Buy Now | Axcella Health | $0.40 | 3392.14% | HC Wainwright & Co. | Ed Arce | — | Initiates | → Buy | Get Alert |
| 06/03/2021 | AXLA | Buy Now | Axcella Health | $0.40 | 2394.39% | Chardan Capital | Keay Nakae | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Axcella Health Inc (AXLA)?
The latest price target for Axcella Health Inc (OTC: AXLA) was reported by HC Wainwright & Co. on February 16, 2023. The analyst firm set a price target for $0.00 expecting AXLA to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axcella Health Inc (AXLA)?
The latest analyst rating for Axcella Health Inc (OTC: AXLA) was provided by HC Wainwright & Co., and Axcella Health Inc maintained their neutral rating.
When was the last upgrade for Axcella Health Inc (AXLA)?
There is no last upgrade for Axcella Health Inc.
When was the last downgrade for Axcella Health Inc (AXLA)?
The last downgrade for Axcella Health Inc happened on December 16, 2022 when SVB Leerink changed their price target from $6 to $2 for Axcella Health Inc.
When is the next analyst rating going to be posted or updated for Axcella Health Inc (AXLA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axcella Health Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axcella Health Inc was filed on February 16, 2023 so you should expect the next rating to be made available sometime around February 16, 2024.
Is the Analyst Rating Axcella Health Inc (AXLA) correct?
While ratings are subjective and will change, the latest Axcella Health Inc (AXLA) rating was a maintained with a price target of $0.00 to $0.00. The current price Axcella Health Inc (AXLA) is trading at is $0.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.